Nationally Recognized Hand and Upper Extremity Specialist Dr. Korsh Jafarnia Among First in Houston to offer New Non-surgical XIAFLEX™ Treatment for Dupuytren’s Contracture
The Specialist of Methodist Orthopedics & Sports Medicine Expands Minimally Invasive Options for Patients in Effort to Bring the Latest Technology in Dupuytren’s Treatment to North Houston and Surrounding Area
HOUSTON – Nationally recognized physician of Methodist Orthopedics & Sports Medicine and director of The Hand Center at Houston Methodist Dr. Korsh Jafarnia continues to set the pace in the orthopedic community by bringing to patients suffering from Dupuytren’s Contracture in north Houston the new non-surgical, scientifically advanced XIAFLEX™ treatment.
Dr. Jafarnia now offers sufferers of Dupuytren’s Contracture a less invasive option for restoring hand function and higher quality of life through a new FDA-approved treatment, which is a biologic product drug-derived of protein from a living organism.
The treatment called, XIAFLEX™, is injected into the collagen cord of the hand – breaking down the excessive collagen buildup that results in debilitating contractures.
According to Dr. Jafarnia hand surgeons have been working towards a treatment for Dupuytren’s Contracture that would not only provide long lasting results but also pose the least amount of disruption to a patient’s daily life, and this treatment is proving to do both.
XIAFLEX is the first non-surgical “enzymatically dissolving” treatment option for the progressive symptoms of Dupuytren’s disease, which is changing the lives of patients apprehensive about traditional surgical intervention. Preliminary results are rivaling those of the most effective Dupuytren’s treatments introduced to date.
“Our goal is to find the best long-term results for some of the most common conditions our patients experience. XIAFLEX is an exciting new treatment option with minimal risk, which allows us to help Dupuytren’s patients overcome a progressively debilitating handicap that is holding them back from all they want to do in life,” said Dr. Korsh Jafarnia chief of Methodist Orthopedics & Sports Medicine and former chief of staff at Houston Methodist Willowbrook Hospital.
Affecting the connective tissue under the skin in the palm of the hand, Dupuytren’s disease is the buildup of collagen – forming thick, rope-like cords of tissue, which prevent the fingers from relaxing and straightening normally. The disorder is more common in Caucasian men over the age of 50.
The board certified hand specialist and published author is also listed among the Super Doctors of Texas published in Texas Monthly magazine and H Texas Top Docs – annual tributes to the best in Texas healthcare.
Dr. Jafarnia is a member of the American Board of Orthopaedic Surgeons (ABOS), the American Society for Surgery of the Hand (ASSH), and the American Academy of Orthopaedic Surgeons (AAOS).
To learn more about Dr. Jafarnia and the treatment options he provides, log onto www.korshjafarniamd.com. You may also call (888) 621-HAND to speak with a representative and schedule a consult.
Comments are closed.